Lactoferrin to help prevent infections in ventilated newborns
Official title: Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.
Run by Tanta University · NCT07255742 · Data updated 2026-11-12
This study tests whether giving lactoferrin to ventilated neonates can help prevent ventilator-associated pneumonia and related complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Days to 90 Days |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT07255742 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Neonates requiring mechanical ventilation for an anticipated duration of at least 48 hours, without congenital lung/airway anomalies, major congenital heart disease, early onset sepsis, severe perinatal asphyxia, or other conditions preventing participation.
✕Probably not a fit
Patients with severe gastrointestinal pathology, known lactoferrin allergy, proven early sepsis at enrollment, or conditions interfering with participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial investigates the preventive use of lactoferrin in neonates who require mechanical ventilation. It compares lactoferrin to a control to see if it reduces the incidence of ventilator-associated pneumonia, sepsis, feeding intolerance, vomiting, constipation or diarrhea, and impacts duration of ventilation and hospital stay. The study targets critically ill neonates without major congenital conditions, and excludes those with early proven sepsis or significant gastrointestinal disease. Outcomes include both the primary effect on VAP and secondary effects on clinical course. Conducted at a neonatal intensive care unit in a university hospital setting, with the lead sponsor and no listed collaborators beyond the site.
Why it matters
Potential benefit: If successful, lactoferrin could reduce VAP and related complications, potentially shortening ventilation time and hospital stay for ventilated neonates.
How similar studies have gone: Prior studies in neonates have explored lactoferrin for infection prevention with mixed results; this trial adds randomized, controlled data for VAP prevention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: neonates requiring mechanical ventilation. Gestational age: Expected need for mechanical ventilation for ≥ (48hours) Exclusion Criteria: Congenital anomalies of the lung or airway. Major congenital heart disease. Proven early-onset sepsis at enrollment. Severe perinatal asphyxia (e.g., Apgar \< 3 at 5 minutes or seizures). Known contraindication or allergy to lactoferrin. Severe gastrointestinal pathology (e.g., NEC stage II or higher). Any condition deemed by the clinical team to interfere with study participation.
Where it's running
-
Neonatal Intensive Care Unit, Tanta University Children's Hospital
Tanta, Egypt Recruiting
Study contacts
- Study coordinator: Dalia Ayoub
- Email: dalia.ayoub@med.tanta.edu.eg
- Phone: +201066343989
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU
We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.
-
B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation
This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.
-
Measuring breathing effort before and after removing the breathing tube
This will test a new electrical impedance method to measure breathing effort in adults on ventilators as they try breathing on their own and after the breathing tube is removed.
-
Rapid multiplex PCR on bronchoalveolar lavage to guide antibiotics for ventilator-associated pneumonia
This trial tests whether using a fast multiplex PCR on bronchoalveolar lavage samples helps doctors choose the right antibiotics sooner for adults on mechanical ventilation suspected of ventilator-associated pneumonia.
-
Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus
This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.
-
Standardized oral care using human milk for premature infants in the NICU
This study is trying to see if giving regular oral care using human milk can help very low birth weight babies in the NICU stay healthier and avoid complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.